Patents by Inventor Richard Ottman

Richard Ottman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for diagnosis and prognosis of epithelial tumors
    Patent number: 10655185
    Abstract: A biomarker is disclosed that can distinguish aggressive epithelial tumors in a tissue biopsy from, for example, normal, hyperplastic, and benign neoplastic tumors. The biomarker can also identify epithelial tumors that have become resistant to hormone therapy. Therefore, methods are disclosed for providing diagnosis and prognosis of a subject having, or suspected of having, an epithelial tumor, such as a prostate tumor.
    Type: Grant
    Filed: November 10, 2015
    Date of Patent: May 19, 2020
    Assignees: H. Lee Moffitt Cancer Center and Research Institute, Inc., University of Center Florida Research Foundation, Inc.
    Inventors: Ratna Chakrabarti, Richard Ottman, Domenico Coppola, Nupam Mahajan
  • METHODS FOR DIAGNOSIS AND PROGNOSIS OF EPITHELIAL TUMORS
    Publication number: 20170335403
    Abstract: A biomarker is disclosed that can distinguish aggressive epithelial tumors in a tissue biopsy from, for example, normal, hyperplastic, and benign neoplastic tumors. The biomarker can also identify epithelial tumors that have become resistant to hormone therapy. Therefore, methods are disclosed for providing diagnosis and prognosis of a subject having, or suspected of having, an epithelial tumor, such as a prostate tumor.
    Type: Application
    Filed: November 10, 2015
    Publication date: November 23, 2017
    Inventors: Ratna Chakrabarti, Richard Ottman, Domenico Coppola, Nupam Mahajan
  • THERAPY FOR DRUG RESISTANT CANCER
    Publication number: 20150238519
    Abstract: Disclosed herein are compositions and methods for treating cancer involving the targeting of FGD4. Alternatively, methods and compositions involve the administration of certain miRNA sequences. The administration is effective to reduce the conversion of cancer cells to an aggressive phenotype.
    Type: Application
    Filed: February 19, 2015
    Publication date: August 27, 2015
    Applicant: University of Central Florida Research Foundation, Inc.
    Inventors: Ratna Chakrabarti, Richard Ottman